Treated or Untreated, COVID Symptoms Can Ease and Then Return, Study Finds
MONDAY, Oct. 31, 2022 (HealthDay News) — Nearly everyone has heard of Paxlovid rebound, where COVID-19 symptoms return after taking the antiviral and then feeling better. It even happened to President Joe Biden. But new research shows it also happens…
Learn MoreHearts From Donors Who Had COVID Are Safe for Transplant
MONDAY, Oct. 31, 2022 (HealthDay News) — A person with heart failure in dire need of a new heart may have faced delays in getting one during the pandemic when potential donors tested positive for COVID-19. As some centers began accepting these hearts…
Learn MoreFDA Warns of Amoxicillin Shortage
MONDAY, Oct. 31, 2022 (HealthDay News) – It could be harder to fill a prescription for the widely used antibiotic amoxicillin because of a shortage that appears to be linked to an ongoing surge in RSV infections across the United States.Supplies of am…
Learn MoreLong COVID Prevalent in U.S. Adults With Prior COVID-19 Infection
FRIDAY, Oct. 28, 2022 (HealthDay News) — Nearly 15 percent of U.S. adults with a prior positive COVID-19 test reported current symptoms of long COVID, according to a study published online Oct. 27 in JAMA Network Open.Roy H. Perlis, M.D., from Massac…
Learn MoreOmicron BA.2 Subvariant Less Severe Than Delta, Original Omicron
FRIDAY, Oct. 28, 2022 (HealthDay News) — The omicron BA.2 subvariant seems to be less severe than the delta variant and the original omicron variant, according to a study published online Oct. 25 in JAMA Network Open.Zachary H. Strasser, M.D., from M…
Learn MoreBlack, Hispanic COVID Patients Less Likely to Get Antiviral Paxlovid
FRIDAY, Oct. 28, 2022 (HealthDay News) — Black and Hispanic patients are less likely to be given antiviral drugs such as Paxlovid to help battle a bout of COVID-19 than white patients are, a new government report shows.In a study of more than 700,000…
Learn MoreDoctors Answer Your Questions About RSV
FRIDAY, Oct. 28, 2022 (HealthDay News) — While a potential COVID winter surge and the impending flu season get a lot of attention, doctors are worried about another virus.This one is RSV — short for respiratory syncytial virus — and hospitals acros…
Learn MoreManifestations of Hospitalization With Severe Monkeypox Described
THURSDAY, Oct. 27, 2022 (HealthDay News) — Most patients hospitalized with severe manifestations of monkeypox have HIV infection, according to research published in the Oct. 26 early-release issue of the U.S. Centers for Disease Control and Preventi…
Learn MoreDisparities ID’d in Dispensing of Oral Antivirals for COVID-19
THURSDAY, Oct. 27, 2022 (HealthDay News) — Disparities are seen in the dispensing of oral antiviral drugs for treatment of COVID-19 based on social vulnerability zip codes, according to research published in the Oct. 28 issue of the U.S. Centers for…
Learn MoreLa ventaja oculta de las ‘quemas controladas’: menos garrapatas
MIÉRCOLES, 26 de octubre de 2022 (HealthDay News) — Una herramienta que se utiliza para restaurar los ecosistemas forestales también podría ser clave en la batalla contra las enfermedades transmitidas por las garrapatas, señalan unos investigadores.L…
Learn More